Secondary amyloidosis in Castleman's disease: Review of the literature and report of a case

Annals of Hematology

Volumn 81, Issue 6, 2002, Pages 336-339

  Altiparmak, M R ^a   Pamuk, G E ^a   Pamuk, O N ^a   Dogusoy G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Castleman's disease; Nephrotic syndrome; Secondary amyloidosis

Indexed keywords

ANTINEOPLASTIC AGENT; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INTERLEUKIN 6 ANTIBODY; MELPHALAN; MEPREDNISONE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PLASMA CELL; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT PLANNING; URINALYSIS; WEIGHT REDUCTION;

AMYLOIDOSIS; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; KIDNEY DISEASES; MIDDLE AGED;

EID: 0036933525     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0444-9     Document Type: Article

References (27)

1. Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 9:822-830
2. Anagonstou D, Hamson CV (1972) Angiofollicular lymph node hyperplasia. J Clin Pathol 25:306-311
3. Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683
4. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H (1985) Multicentric angiofollicular lymph node hyperplasia: a clinicopathological study of 16 cases. Human Pathol 16: 162-172
5. Urbano-Marquez A, Estruch R, Grau JM, Llebaria C, Pastor M, Rozman C (1984) Generalized Castleman's disease with urinary elimination of heavy chain fragments. Acta Haematol 71:400-406
6. Humphreys SR, Holley KE, Smith LH, McIlrath DC (1975) Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephrotic syndrome. Mayo Clin Proc 50: 317-321
7. Kazes I, Deray G, Jacobs C (1995) Castleman disease and renal amyloidosis. Ann Intern Med 122:395-396
8. Lui SL, Chan KW, Li FK, Cheng IK, Chan TM (1998) Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. Nephron 78:323-327
9. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al (1999) The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 85:706-717
10. Said R, Tarawneh M (1992) Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature. Am J Nephrol 12:466-470
11. Moir DH, Choy T, Dalton WR (1982) Giant lymph node hyperplasia: persistence of symptoms for 15 years. Cancer 49: 748-750
12. Bartoli E, Massarelli G, Soggia G, Tanda F (1980) Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course. Am J Clin Pathol 73: 423-426
13. Funabiki K, Kaneko S, Terajima M, Tomita H, Kawano Y, Tomino Y (1998) A case of multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia. Am J Nephrol 18:247-250
14. Stone MJ (1990) Amyloidosis: a final common pathway for protein deposition in tissues. Blood 75:531-545
15. Yokizawi K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al (1989) Pathogenetic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367
16. Frizzara G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphological features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216
17. Montoli A, Minola E, Stabile F, Grillo C, Radaelli L, Spanti D, et al (1995) End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease). Am J Nephrol 15:142-146
18. Chan WC, Hargreaves H, Keller J (1984) Giant lymph node hyperplasia with unusual clinicopathologic features. Cancer 53:2135-2139
19. Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, et al (2000) Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95:56-61
20. Paydaş S, Gönlüşen G, Saǧlιker Y (1995) Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease. Nephron 71:463-464
21. Pilon VA, Gomez LG, Butler JJ (1982) Systemic amyloidosis associated with a benign mesenteric lymphoid mass. Am J Clin Pathol 78:112-116
22. Bonneau R, Paquin F, Giroux L (1982) Angiofollicular lymph node hyperplasia of the plasma cell type with nephrotic syndrome and systemic amyloidosis (abstract). Lab Invest 46:10-11
23. West KP, Morgan DR, Lauder I (1989) Angiofollicular lymph node hyperplasia with amyloidosis. Postgrad Med J 65: 108-111
24. Tanaka K, Horita M, Shibayama H, Seike M, Itoh Y, Hamaguchi K, et al (1995) Secondary amyloidosis associated with Castleman's disease. Intern Med 34:122-126
25. Moon WK, Kim SH, Im JG, Yeon KM, Han MC (1995) Castleman disease with renal amyloidosis: imaging findings and clinical significance. Abdom Imaging 20:376-378
26. Arιnsoy T, Yιlmaz M, Ataoǧlu P, Bali M, Sindel, Ş (1997) Castleman's disease with renal amyloidosis and nephrotic syndrome. Nephrol Dial Transplant 12:2713-2716
27. Keven K, Nergizoglu G, Ates K, Erekul S, Orhan D, Erturk S, et al (2000) Remission of nephrotic syndrome after removal of localized Castleman's disease. Am J Kidney Dis 35: 1207-1211